TWO studies by different groups
have found 100% protection against
AIDS in monkeys that received
monthly injections of antiretroviral
drugs.
There was evidence that one
injection every three months could
work on humans as well, the New
York Times reported.
‘Long-Acting Integrase Inhibitor
Protects Macaques from Intrarectal
Simian/Human Immunodeficiency
Virus’, published in Science, said
the injections could decrease
adherence problems associated
with daily preexposure prophylaxis,
or taking antiretrovirals daily.
To read the abstract, CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 14
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.